H M. Schellens - Publications

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 20, 2021

Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: September 06, 2021

Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 16, 2020

Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization.

Journal: Cancer chemotherapy and pharmacology

Published: June 12, 2020

Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors.

Journal: Cancer chemotherapy and pharmacology

Published: May 28, 2020

Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results.

Journal: The British journal of surgery

Published: December 18, 2019

Pilot Study to Predict Pharmacokinetics of a Therapeutic Gemcitabine Dose From a Microdose.

Journal: Clinical pharmacology in drug development

Published: November 15, 2019

Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib.

Journal: BMC cancer

Published: November 27, 2018

AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies.

Journal: Investigational new drugs

Published: March 20, 2015